We bring you another edition of Peer to Peer with David Rubenstein from Bloomberg Television. This week, David speaks with Gates Foundation Co-Founder Melinda Gates about  inequality in the U.S.

We bring you another edition of Peer to Peer with David Rubenstein from Bloomberg Television. This week, David speaks with Gates Foundation Co-Founder Melinda Gates about  inequality in the U.S.

What makes a great leader? How can leadership be developed into a force for true achievement? The David Rubenstein Show: Peer-to-Peer Conversations explores successful leadership through the personal and professional choices of the most influential people in business. Renowned financier and philanthropist David Rubenstein travels the country talking to leaders to uncover their stories and their path to success. Each episode features an interview with one business leader.

Renowned financier and philanthropist David Rubenstein travels the country talking to leaders to uncover their stories and their path to success

The David Rubenstein Show

Melinda Gates

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0ec2d65f-00e2-43e7-b96f-ae3c000a5eda/transcript

Bridgewater Associates CEO Nir Bar Dea sits down with David Rubenstein for a wide-ranging conversation about the US economy, rising national debt, the dollar and explains how he sees AI reshaping the future of investing. He also reflects on his unconventional path to Wall Street; from struggling in school and spending six years in the IDF to becoming Bridgewater's oldest intern and eventually its CEO. He's on this week's episode of The David Rubenstein Show: Peer to Peer Conversations. This interview was recorded September 25 in New York.

Bridgewater Associates CEO Nir Bar Dea sits down with David Rubenstein for a wide-ranging conversation about the US economy, rising national debt, the dollar and explains how he sees AI reshaping the future of investing. He also reflects on his unconventional path to Wall Street; from struggling in school and spending six years in the IDF to becoming Bridgewater's oldest intern and eventually its CEO. He's on this week's episode of The David Rubenstein Show: Peer to Peer Conversations. This interview was recorded September 25 in New York.

Nir Bar Dea

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a5c04b11-f186-40a8-a555-b4f10147a2e3/transcript

Santander Executive Chair Ana Botin sits down with David Rubenstein to discuss the bank's expansion in the US, including its recent acquisition of Webster Financial, and why she sees lack of economic growth as one of the biggest challenges facing the global economy. She also discusses US debt, the outlook for the US and European economies amid geopolitical uncertainty, and the impact of AI on banking and jobs. Botin is on this week's episode of The David Rubenstein Show: Peer to Peer Conversations. This episode was recorded July 13 in New York.

Santander Executive Chair Ana Botin sits down with David Rubenstein to discuss the bank's expansion in the US, including its recent acquisition of Webster Financial, and why she sees lack of economic growth as one of the biggest challenges facing the global economy. She also discusses US debt, the outlook for the US and European economies amid geopolitical uncertainty, and the impact of AI on banking and jobs. Botin is on this week's episode of The David Rubenstein Show: Peer to Peer Conversations. This episode was recorded July 13 in New York.

Ana Botin

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/18c8a37c-49de-4f94-a93b-b4e400de5cde/transcript

Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duato also talked about how artificial intelligence could accelerate drug discovery and the development of new medicines. He's on this week's episode of The David Rubenstein Show: Peer to Peer Conversations. This interview was recorded June 16 at The Economic Club of Washington.

Johnson &amp; Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&amp;J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duato also talked about how artificial intelligence could accelerate drug discovery and the development of new medicines. He's on this week's episode of The David Rubenstein Show: Peer to Peer Conversations. This interview was recorded June 16 at The Economic Club of Washington.

Joaquin Duato

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/17aae89d-b412-4f89-be5c-b4dd00e76e6e/transcript

Melinda Gates

In 1 playlist(s)

The David Rubenstein Show

Social links

Follow podcast

Recent clips